View on Pubmed.gov 32934239 | View on doi.org 10.1038/s41467-...
A predictive index for health status using species-level gut microbiome profiling.
- Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
- Division of Surgery Research, Department of Surgery, Mayo Clinic, Rochester, MN, 55905, USA.
- Graduate Research Education Program (GREP), Mayo Clinic, Rochester, MN, 55905, USA.
- Department of Computer Science and Engineering, University of Minnesota Twin-Cities, Minneapolis, MN, 55455, USA.
- Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
- Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, MN, 55905, USA.
- Emeritus Chair, Department of Surgery, Mayo Clinic, Rochester, MN, 55905, USA.
- Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, 55905, USA. Sung.Jaeyun@mayo.edu.
- Division of Surgery Research, Department of Surgery, Mayo Clinic, Rochester, MN, 55905, USA. Sung.Jaeyun@mayo.edu.
- Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA. Sung.Jaeyun@mayo.edu.
Abstract
Providing insight into one's health status from a gut microbiome sample is an important clinical goal in current human microbiome research. Herein, we introduce the Gut Microbiome Health Index (GMHI), a biologically-interpretable mathematical formula for predicting the likelihood of disease independent of the clinical diagnosis. GMHI is formulated upon 50 microbial species associated with healthy gut ecosystems. These species are identified through a multi-study, integrative analysis on 4347 human stool metagenomes from 34 published studies across healthy and 12 different nonhealthy conditions, i.e., disease or abnormal bodyweight. When demonstrated on our population-scale meta-dataset, GMHI is the most robust and consistent predictor of disease presence (or absence) compared to α-diversity indices. Validation on 679 samples from 9 additional studies results in a balanced accuracy of 73.7% in distinguishing healthy from non-healthy groups. Our findings suggest that gut taxonomic signatures can predict health status, and highlight how data sharing efforts can provide broadly applicable discoveries.
References
Nature. 2012 Jun 13;486(7402):207-14
Nat Commun. 2016 Jun 28;7:12015
J Psychiatry Neurosci. 2017 Mar;42(2):75-77
Science. 2019 Jan 25;363(6425):350-352
Cited by 227 citations (total)
Journal Article Research Support, Non-U.S. Gov't
Faecal microbiome-based machine learning for multi-class disease diagnosis.
Electronic publication date November 15, 2022
Qi Su [...] Siew C Ng et al.
Systemic characterisation of the human faecal microbiome provides the opportunity to develop non-invasive approaches in the diagnosis of a major...
Journal Article Research Support, Non-U.S. Gov't
TaxiBGC: a Taxonomy-Guided Approach for Profiling Experimentally Characterized Microbial Biosynthetic Gene Clusters and Secondary Metabolite Production Potential in Metagenomes.
Electronic publication date December 23, 2022
Vinod K Gupta [...] Jaeyun Sung et al.
Biosynthetic gene clusters (BGCs) in microbial genomes encode bioactive secondary metabolites (SMs), which can play important roles in microbe-microbe and...
Conflict of interest statement
MeSH
- •
Specialties
- •
- •
- •